NCT00080860View on ClinicalTrials.gov

Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

August 31, 2007

Conditions
Breast Cancer
Interventions
GENETIC

microarray analysis

OTHER

immunohistochemistry staining method

PROCEDURE

conventional surgery

PROCEDURE

lymphangiography

PROCEDURE

radionuclide imaging

PROCEDURE

sentinel lymph node biopsy

RADIATION

technetium Tc 99m sulfur colloid

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00080860 - Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer | Biotech Hunter | Biotech Hunter